How is an ultrasound‑guided middle cluneal nerve block performed, including medication dosage, patient positioning, and post‑procedure care?

Ultrasound-Guided Middle Cluneal Nerve Block: Technical Approach

The middle cluneal nerve block is performed using ultrasound guidance with the patient prone, injecting 3-5 mL of local anesthetic (typically 0.5% bupivacaine or 0.2-0.5% ropivacaine) at the nerve's emergence point near the posterior superior iliac spine, with immediate pain relief expected for 4-6 weeks. 1

Patient Positioning

Position the patient prone with a pillow under the hips to flatten the lumbar lordosis and optimize visualization of the sacral region. This positioning allows direct access to the posterior superior iliac spine (PSIS) area where the middle cluneal nerves emerge.

Equipment Setup

• High-frequency linear ultrasound probe (10-15 MHz) for superficial nerve visualization 2
• Position the ultrasound machine opposite the operator at eye level to minimize neck flexion and maintain ergonomic positioning 2
• Use in-plane needle guidance technique for continuous visualization of needle advancement 3
• 22-25 gauge needle, 2-3 inches in length 1

Sonoanatomy and Needle Technique

The middle cluneal nerves originate from the dorsal rami of S1-S3 and pierce the thoracolumbar fascia near the PSIS. Unlike superior cluneal nerves which cross the iliac crest, middle cluneal nerves emerge more medially over the sacrum.

Probe placement: Position the linear probe transversely over the PSIS, then move medially 1-2 cm to identify the sacral bone and overlying thoracolumbar fascia. The nerves appear as small hypoechoic oval structures beneath the fascia.

Needle approach: Use an in-plane lateral-to-medial approach, advancing the needle through the subcutaneous tissue toward the thoracolumbar fascia where the nerves emerge. Confirm needle tip position before injection.

Medication Dosing

Primary choice: Ropivacaine - preferred due to lower systemic toxicity and reduced motor blockade 3

• Volume: 3-5 mL per side (bilateral blocks typically performed)
• Concentration: 0.2-0.5% ropivacaine or 0.5% bupivacaine 1
• Maximum dose: Stay well below 3 mg/kg for ropivacaine to avoid systemic toxicity 3

Without corticosteroid: The case series demonstrated effective analgesia using local anesthetic alone, avoiding immunosuppressive effects of steroids 1

Adjuvants (if extended duration needed): Consider 1-2 µg/kg dexmedetomidine, though balance against risks of sedation and hypotension 3, 4

Critical Safety Considerations

Aspiration before injection is mandatory - the sacral region has rich vascular supply. Use color Doppler to identify and avoid vascular structures before needle advancement 4, 5.

Volume-concentration balance: This is a "concentration block" targeting specific nerves, not a fascial plane "volume block." Do not compensate low volume with high concentration or vice versa 3. Precise perineural administration is essential.

Local anesthetic systemic toxicity (LAST): Though rare (8 in 100,000), have 20% Intralipid immediately available: 1.5 mL/kg over 1 minute, then 0.25 mg/kg/min infusion, with repeat boluses every 5 minutes if needed 3.

Block Assessment and Duration

Immediate assessment: Test for sensory blockade over the sacroiliac region and upper gluteal area within 15-30 minutes. A positive response is ≥50% pain reduction 5.

Expected duration: Single-shot blocks provide 4-6 weeks of analgesia based on clinical evidence 1. This is substantially longer than typical peripheral nerve blocks, likely due to the superficial nature and reduced metabolic activity in this region.

Post-Procedure Care

Monitoring: Standard post-block observation for 30 minutes, watching for signs of LAST (perioral numbness, tinnitus, confusion, seizures, cardiovascular collapse) 3.

Repeat blocks: Can be performed every 4-6 weeks as needed. The case series documented 7 successful repeat blocks over 11 months without complications 1.

Alternative approaches if inadequate relief: Consider radiofrequency ablation, peripheral nerve stimulation, or alcohol neurolysis for longer-term management if repeated blocks prove effective but duration is insufficient 1.

Common Pitfalls

• Confusing middle with superior cluneal nerves: Superior cluneal nerves cross the iliac crest more laterally; middle cluneal nerves emerge medially over the sacrum
• Inadequate depth: Ensure injection reaches the thoracolumbar fascia level where nerves emerge
• Single-sided block: Most patients require bilateral blocks for adequate coverage
• Excessive volume: Using fascial plane block volumes (20-30 mL) is unnecessary and increases toxicity risk; 3-5 mL per side is sufficient